The use of TMX as a monotherapy tended to increase the risk of developing osteoporosis; however, it did not reach statistical significance (HR, 1.04; 95% CI, 0.95–1.13).
← all excerpts
Effects of Anticancer Therapy on Osteoporosis in Breast Cancer Patients: A Nationwide Study Using Data from the National Health Insurance Service-National Health Information Database.
1
—
—